Sponsor:
Hennepin Healthcare Research Institute
Code:
NCT06514547
Conditions
HIV Infections
Age
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Conjugate Pneumococcal Vaccine 20 (PCV20)
Brief summary:
Conditions
HIV Infections
Age
Study ID
NCT06514547
Start date
Jul 8, 2024
Status verified date
Jun, 2025
Completion date
Jun 30, 2029
Anticipated
Primary completion date
Sep 15, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
250 participants
Anticipated
Intervention Model
Single group
Primary purpose
Basic Science
Arms
experimental: Pneumococcal Vaccination
Interventions
Conjugate Pneumococcal Vaccine 20 (PCV20)
Primary outcome measure
Central contacts
Locations
Hennepin Healthcare System
Recruiting
Minneapolis, Minnesota, United States, 55415
Sponsor
Hennepin Healthcare Research Institute
Last update posted
Jun 12, 2025
Last verified
Jun, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Hennepin Healthcare Research Institute on 2025-06-12.